Lithium is a naturally occurring trace mineral found in varying amounts in drinking water and certain foods, and at low doses it has attracted growing research interest for its potential role in brain health. Studies indicate that low-dose lithium may support neuroprotection by promoting the production of brain-derived neurotrophic factor and inhibiting glycogen synthase kinase-3, enzymes involved in neuronal stress and inflammation. Research suggests that populations with higher natural lithium levels in their water supply tend to show lower rates of cognitive decline and more stable mood patterns, though these are observational findings. Commonly available as lithium orotate or lithium aspartate, low-dose lithium is being explored as a nutritional approach to supporting long-term cognitive function, though more controlled clinical trials are needed to fully understand its benefits.
Compare this supplementResearch suggests that low-dose lithium may offer modest but meaningful benefits for cognitive function, particularly...
View studies →Research suggests that low-dose lithium may support cognitive health through anti-inflammatory and neuroprotective me...
View studies →The studies provided in this dataset do not appear to contain research directly investigating low-dose lithium for mo...
View studies →Research suggests that low-dose lithium may exert meaningful neuroprotective effects through multiple biological mech...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 5–10 mg | Daily | Mood support and general neuroprotection | Common low-dose lithium orotate range referenced in observational and pilot studies |
| Capsule | 10–20 mg | Daily | Neuroprotection and mood stabilization at low supplemental doses | Referenced in pilot studies and reviews on low-dose lithium orotate supplementation |
| Tablet | 0.3–0.5 mg | Daily | Cognitive decline support and neuroprotection in older adults | Based on RCTs including Nunes et al. (2013) using lithium orotate/aspartate at microdose levels |
| Tablet | 150–300 mcg | Daily | Cognitive function and mood support at near-nutritional levels | Epidemiological studies examining naturally occurring lithium in drinking water and cognitive/mood outcomes |
| Tablet | 1 mg | Daily | Mild cognitive impairment and Alzheimer's disease neuroprotection | Used in clinical trials such as Nunes et al. (2013, J Alzheimers Dis) with lithium carbonate microdose |